Advertisement

Reactions Weekly

, Volume 1748, Issue 1, pp 24–24 | Cite as

Adalimumab

Hepatic abscess, psoriasis and basal cell epithelioma: 3 case reports
Case report
  • 12 Downloads

Reference

  1. Sartini A, et al. Retention Rate, Persistence and Safety of Adalimumab in Inflammatory Bowel Disease: A Real-Life, 9-Year, Single-Center Experience in Italy. Digestive Diseases and Sciences 64: 863-874, No. 3, Mar 2019. Available from: URL: http://doi.org/10.1007/s10620-018-5329-4 - ItalyCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations